On-Demand Webinars

  1. Measuring Treatment Tolerability In Oncology: Expert Panel Discussion 2/19/2026

    Learn how to synthesize individual symptomatic data into a comprehensive narrative of tolerability, ultimately enhancing the clinical value and regulatory positioning of your oncology assets.

  2. Rethinking Today's ePRO Delivery For Tomorrow's Clinical Trials 6/24/2024

    Willie Muehlhausen, Co-CEO and Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery needs to change to better serve modern trials.

  3. Benefits Of Leveraging Real World Data (RWD) To Conduct Long-Term Follow Up 8/24/2022

    In this webinar, panelists discuss how connecting sources of real world data (RWD) to clinical trial enables many benefits, including the ability to supplement data for patients lost to follow up and augment trial data to help explain non-responders and adverse events.

  4. What It Really Takes To Adopt eConsent Across Large Pharma 3/27/2024

    Explore the benefits of incorporating consent management technology and discover practical strategies for developing effective change management and training programs.

  5. Bridging The Gap: EHR To EDC Integration In Clinical Trials 9/9/2025

    This distinguished panel of industry experts shares an engaging and honest discussion about the current state and future potential of EHR-to-EDC integration.

  6. The Connected Patient In Clinical Trials 12/23/2025

    Discover how digital innovation and patient-centric technologies are reshaping clinical trials by improving access, efficiency, and data-driven insights.

  7. Reduce TMF Misfiles & Metadata Errors With Next-Gen AI-Enabled eTMF 4/17/2023

    Listen in as Chief Product Officer Jim Nichols, Product Manager Jim Horstmann, and VP Solutions Consulting Aaron Grant discuss issues and solutions for trial master files.

  8. Navigating Successful eConsent Adoption From Sponsor To Site 10/17/2023

    Drawing inspiration from real-world instances within the pharmaceutical and medical device sectors, watch as industry experts unravel the pivotal role of eConsent in optimizing modern clinical trials.

  9. Redefining ALS Clinical Endpoints: Unlocking The Potential Of DHTs 11/11/2021

    Drug development in neurology is notoriously challenging. Despite being one of the most active areas of clinical development, neurological disease drug trials have among the longest development timelines and highest failure rates in the industry. In this webinar, learn how digital clinical measures enabled by wearables have great potential to transform and accelerate drug development in neuroscience.

  10. Leverage DHT Data As Patient-Centric Primary Endpoints 5/23/2023

    See how digital outcome measures of physical activity collected from ActiGraph technology as the primary endpoint in a pivotal cardiopulmonary trial were endorsed by the FDA, marking an important milestone.